Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Foundation Medicine Inc (NASDAQ:FMI)

18.50
Delayed Data
As of May 27
 +0.22 / +1.20%
Today’s Change
13.34
Today|||52-Week Range
36.70
-12.16%
Year-to-Date
No recent news for Foundation Medicine Inc.

Today’s Trading

Previous close18.28
Today’s open18.26
Day’s range18.10 - 18.67
Volume113,100
Average volume (3 months)227,026
Market cap$632.5M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-45.99%
Earnings growth (this year)-10.57%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.59%
P/E ratioNM
Price/Sales7.42
Price/Book2.45

Competitors

 Today’s
change
Today’s
% change
RTRXRetrophin Inc+0.25+1.45%
NKNantKwest Inc+0.24+3.35%
ANIPANI Pharmaceuticals ...+0.63+1.22%
RLYPRelypsa Inc+1.46+8.80%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJuly 27, 2016
EPS forecast (this quarter)-$0.78
Annual revenue (last year)$93.2M
Annual profit (last year)-$89.6M
Net profit margin-96.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Michael J. Pellini
President &
Chief Operating Officer
Steven J. Kafka
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers

Search for Jobs